TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data Private Market Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / EarLens Stock

EarLens Stock

earlens.comHealthcare / Other HealthcareFounded: 2005Funding to Date: $249.38MM

Earlens Corporation is a medical device company committed to providing hearing impaired patients with a state-of-art hearing solution that is designed to change the current standard of care for sound performance.

Buy or sell EarLens stockLearn more about EarLens IPO

Register To Buy and Sell Shares

For more details on financing and valuation for EarLens, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access EarLens’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like EarLens.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

George Harter Jr.
Chief Financial Officer
Leilani Latimer
Chief Marketing Officer
Rodney Perkins MD
Founder, Chief Medical Officer & Board Member
William Facteau
Chief Executive Officer, President & Board Member

Board Members

Henry Plain Jr.
Lightstone Ventures
Nael Kassar
KCK Group
Ryan Drant
New Enterprise Associates
Vincent Racano
William Facteau
Greg Garfield JD
KCK Group
Robert Croce
Steven Elms
Aisling Capital
Yoh-Chie Lu
Vertex Ventures HC
Frank Torti MD
New Enterprise Associates
Michael Favet
KCK Group
Rodney Perkins MD
Thomas Prescott
Arthur Taylor

Frequently Asked Questions About EarLens’ Stock

plusminus
Can you buy EarLens stock?
EarLens is not publicly traded on NYSE or NASDAQ in the U.S. To buy EarLens stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell EarLens stock?
Yes, you can sell stock of a private company like EarLens. Forge can help you sell your EarLens stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is EarLens’ stock price?
EarLens is a privately held company and therefore does not have a public stock price. However, you may access EarLens’ private market stock price with Forge Data.
plusminus
What is EarLens’ stock ticker symbol?
EarLens does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like EarLens in the Other Healthcare sector

Insightec

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$500MM

SHINE Medical Technologies

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$368.08MM

Enlitic

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$125MM

Blink Health

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$829.2MM

Nutrafol

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$150MM

Phil

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$300.91MM

Parallel

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$2.47B

Dascena

Sector
Healthcare / Other Healthcare
Last Round Est. Valuation
$138MM

Allurion Technologies

Sector
Healthcare / Other Healthcare
 
 

News Highlights

PR Newswire 01/13/2020
Earlens Announces Partnership with Verily to Develop Next-Generation Capabilities for Earlens® Contact Hearing Solution
/PRNewswire/ -- Earlens Corporation, a medical technology company that has created the world's first nonsurgical hearing solution that directly vibrates the...
PR Newswire 06/05/2017
Earlens Announces Final Close of $118 Million Debt and Equity Financing
/PRNewswire/ -- Earlens Corporation, Inc., a privately held medical technology company that created and commercialized a revolutionary hearing aid, today...
FinSMEs 06/05/2017
Earlens Closes $118M Debt and Equity Financing |FinSMEs
Earlens Corporation, Inc., a Menlo Park, CA-based medical technology company, closed $118M debt and equity financing. The deal included: – a $73m Series C financing led by Vertex Healthcare with participation from Cochlear Ltd, CRG, RK Mellon, Windham Venture Partners, Sightline Partners, New Enterprise Associates, Aisling Capital, Lightstone Ventures, and Medtronic, and – the establishment …

Trending Companies

Frequently Asked Questions

Updated on: Dec 10, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.